XCXiujie Cui

Xiujie Cui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiujie Cui has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Xing Qi

    Department of Gastroenterology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China

    3 shared publications
  • Guangchun Li

    Department of Gastroenterology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China

    2 shared publications
  • Honglei Wu

    Department of Gastroenterology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China

    2 shared publications
  • Xinpei Wang

    Shandong University, Jinan, China

    2 shared publications
  • Zhenxiang Zuo

    Department of Hematology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China

    2 shared publications
  • Zhiyan Liu

    Department of Pathology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    2 shared publications

Latest Publications

  • Open Access

    Clinicopathologic features of superficial esophageal squamous cell carcinoma in different infiltrative growth pattern

    by Xing Qi, Zhenxiang Zuo, Bin Yu, Huimin Zhang, Xiujie Cui, Guangchun Li, Honglei Wu

    Introduction: Superficial esophageal squamous cell carcinoma (SESCC) is defined as neoplastic lesions limited to the mucosa or submucosa regardless of the nodal status. The infiltrative growth pattern (INF) has been implicated in tumor aggressiveness and prognosis in various cancers, but the application research of INF in SESCC is still unclear. We aimed to investigate the association between INF types and clinicopathological features in SESCC.Methods: We retrospectively analyzed 368 SESCC patients who underwent endoscopic submucosal dissection and precisely defined INF classification from 2014 to 2023. INF was classified as INFa/b/c per Japanese Esophageal Society guidelines. Clinicopathological characteristics were compared across INF types using univariate analysis. Significant variables from univariate analysis were included in multivariate logistic regression to identify independent predictors of INF types.Results: Univariate analysis revealed that the INF of tumor was associated with tumor size, gross morphology, intraepithelial papillary capillary loop (IPCL), infiltration depth, lymphovascular invasion, and vertical positive margins (All P < 0.05). Multivariate logistic regression demonstrated that tumor size (β=0.28, P=0.004; OR=1.32, 95%CI:1.09-1.59), IPCL (β=0.81, P=0.004; OR=2.24, 95%CI:1.30-3.85), and infiltration depth (β=0.81, P=0.017; OR=2.24, 95%CI:1.15-4.35) were significantly correlated with INFb, while lymphovascular invasion (β=8.77, P=0.007; OR=6456.93, 95%CI:10.96-3803785.49) as an independent risk factor for INFc.Conclusion: Increased tumor size, presence of IPCL type B2, and depressed gross morphology were more indicative of INFc-type SESCC. Compared with INFa and INFb, INFc type SESCC has deeper infiltration depth and is more likely to have lymphovascular invasion and positive postoperative resection margins. Therefore, careful endoscopic visualization of tumor size, IPCL, and gross morphology can improve the prediction of INF and tumor status, facilitating informed preoperative selection of surgical approach and subsequent postoperative treatments.


  • Open Access

    Case Report: A case of synchronous multiple early gastric cancer with a microsatellite instability-high phenotype

    by Xinshuo Wang, Yifan Zhang, Guangyan Fan, Honglei Wu, Xing Qi, Xiujie Cui, Chengjun Zhou

    Synchronous multiple early gastric cancer (SMEGC) is a relatively uncommon variant of early gastric cancer (EGC). In this report, we present a case of SMEGC accompanied by a microsatellite instability-high (MSI-H) phenotype. The patient was a 69-year-old man who presented to our hospital with abdominal pain. The endoscopic examination revealed two lesions. Both lesions were pathologically confirmed as EGC, then the patient subsequently underwent endoscopic submucosal dissection (ESD). Nine months post-procedure, the patient returned with recurrent abdominal pain, leading to the diagnosis of a new EGC. Immunohistochemical analysis demonstrated that all lesions exhibited an MSI-H phenotype and BRAF mutant expression, suggesting that these lesions are not associated with Lynch syndrome-related EGC. The case was ultimately diagnosed as SMEGC with an MSI-H phenotype. The current evidence and clinical experience suggest that patients with advanced MSI-H are likely to benefit from immunotherapy and should be considered for early systemic treatment with immunotherapy as a central component. At present, research studies on the molecular characteristics of SMEGC are limited, underscoring the importance of conducting comprehensive molecular diagnostics of each EGC patient, which could help clinicians thoroughly understand the lesion’s characteristics.

  • Open Access

    Case Report: A rare case of early esophageal basaloid squamous cell carcinoma with ductal differentiation

    by Xing Qi, Zhenxiang Zuo, Guangchun Li, Xiujie Cui, Honglei Wu

    Background: Early esophageal basaloid squamous cell carcinoma (EBSCC) with ductal differentiation is a rare variant of esophageal cancer (EC), for which the clinical behavior, endoscopic features and diagnostic criteria are not fully elucidated.Case presentation: An 81-year-old female presented to our hospital with a year of eating obstruction sensation. A rough, superficial-elevated and circumferential 1/2 esophageal lesion on the upper esophagus was found by the white light endoscopy (WLE). The uplift and swelling caused by subepithelial lesions suggest that this lesion may infiltrate into the submucosa. Under the narrow band imaging magnifying endoscopy (NBI-ME), papillary-like structures were visible in the lesion, and the loop capillaries classified as intraepithelial papillary capillary loop (IPCL) of type B1 were observed. Furthermore, a fine network pattern of microvascular similar to the surface glandular structure in early differentiated gastric cancer can be seen in the middle of type B1, indicating that the presence of special glandular tubular-like components. Microscopically, the tumor was a poorly differentiated EBSCC with a glandular structure. In addition, the tubular structures transitional with the surface squamous cell carcinoma. Immunohistochemical results showed that the bilayer-tubular structures exhibited bidirectional differentiation towards the outer basal epithelium and the inner columnar epithelium. The double-layer epithelium cells of the tumorous tubules expressed CK7, and the outer cells expressed p40, CK5/6.Conclusion: Early EBSCC with ductal differentiation has unique endoscopic, histological and immunophenotypic characteristics. Understanding of the endoscopic and pathological features of the early EBSCC with ductal differentiation is crucial for early detection, accurate diagnosis, timely treatment, and prevention of misdiagnosis.


  • Open Access

    Long-Term Exposure to Decabromodiphenyl Ether Promotes the Proliferation and Tumourigenesis of Papillary Thyroid Carcinoma by Inhibiting TRß

    by Xinpei Wang, Xiujie Cui, Qian Zhao, Feifei Sun, Ru Zhao, Tingting Feng, Shaofeng Sui, Bo Han, Zhiyan Liu

    Polybrominated diphenyl ethers (PBDEs) have been reported to possess endocrine-disrupting and tumour-promoting activity. However, the effects of long-term exposure to decabromodiphenyl ether (BDE209) on thyroid tumourigenesis of papillary thyroid carcinoma (PTC) and the underlying mechanisms remain poorly defined. In this study, functional assays in vitro and mouse models in vivo were used to evaluate the toxic effects of long-term exposure to environmental concentrations of BDE209 on the pathogenesis and progression of PTC. MTS, EdU and colony-forming assays confirmed the chronic toxicity of BDE209 on the proliferation of human normal follicular epithelial cell line (Nthy-ori 3-1) and PTC-derived cell lines (TPC-1 and BCPAP). Wound and Transwell assays showed that BDE209 exacerbated the aggressiveness of PTC cells. BDE209 significantly promoted cell proliferation during the S and G2/M phases of the cell cycle. Mechanistically, BDE209 altered the thyroid system by acting as a competitive inhibitor of thyroid receptor beta (TRß) expression and function, which was further proven by public databases and RNA-seq bioinformation analysis. Taken together, these results demonstrated that BDE209 has chronic toxicity and potential tumourigenic effects on the thyroid by inhibiting TRß.